NCT03967080 Adaptive Radiotherapy for High-risk Prostate Cancer Using Multiparametric MRI Status COMPLETED Phase N/A
NCT03964337 Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer Status TERMINATED Phase PHASE2
NCT03961737 Study of the Response to Irradiation on Prostatic Explants ex Vivo, as a Predictive Factor of the Clinical Response to Irradiation of Prostate Cancers Status UNKNOWN Phase NA
NCT03961217 Return to Work Among Cancer Survivors With Treatment-induced Survivorship Syndromes Status COMPLETED Phase N/A
NCT03960112 Multicentric Evaluation of the True Negative Predictive Value of Multiparametric MRI for the Detection of Prostate Cancer Using Cystoprostatectomy Specimen as Reference Status UNKNOWN Phase NA
NCT03957252 Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03956108 Active Surveillance for Low-risk Prostate Cancer - Evaluation of the Efficacy of Minimally Invasive Active Surveillance Status COMPLETED Phase NA
NCT03950180 Assessing The Impact Of Incorporating Charlson Comorbidity Scores On Patient Anxiety And Satisfaction Status COMPLETED Phase NA
NCT03949517 68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU Therapy Status COMPLETED Phase PHASE1/PHASE2
NCT03938766 Upregulation of PSMA Receptors After Androgen Deprivation Therapy on PSMA PET/CT Imaging in Prostate Cancer Status COMPLETED Phase NA
NCT03936296 Prostate Cancer Detection Rates of Standard Transrectal Prostate Biopsy and MR-guided Fusion Transrectal Prostate Biopsy Status COMPLETED Phase NA
NCT03936127 Comparison of a Novel Transperineal Targeted Fusion Biopsy System to Conventional Transrectal Targeted Fusion Biopsy Status UNKNOWN Phase NA
NCT03934840 CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone Status COMPLETED Phase PHASE2
NCT03934827 MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour Status UNKNOWN Phase PHASE1
NCT03934606 Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model Status COMPLETED Phase N/A
NCT03933670 Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance Status RECRUITING Phase PHASE2